Zhicai Yang
Albany Molecular Research, Inc.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zhicai Yang.
Journal of Organic Chemistry | 2009
Zhicai Yang; Phung Tang; Jolicia F. Gauuan; Bruce F. Molino
The asymmetric total synthesis of (+)-crassalactone D (4), a naturally occurring antitumor agent, has been achieved by employing an oxidative spirocyclization of furan 11 as the key step. Two close analogues, 7-epi-crassalactone D (14) and 5-epi-7-epi-crassalactone D (15), also have been prepared in the course of the synthesis of (+)-crassalactone D.
Bioorganic & Medicinal Chemistry Letters | 2010
Zhicai Yang; David J. Fairfax; Jun-Ho Maeng; Liaqat Masih; Alexander Usyatinsky; Carla Hassler; Soshanna Isaacson; Kevin Fitzpatrick; Russell Joseph Deorazio; Jianqing Chen; James P. Harding; Matthew Isherwood; Svetlana Dobritsa; Kevin L. Christensen; Jonathan D. Wierschke; Brian I. Bliss; Lisa H. Peterson; Cathy M. Beer; Christopher L. Cioffi; Michael A. Lynch; W. Martin Rennells; Justin J. Richards; Timothy Rust; Yuri L. Khmelnitsky; Marlene L. Cohen; David D. Manning
A new class of 2-substituted benzoxazole carboxamides are presented as potent functional 5-HT(3) receptor antagonists. The chemical series possesses nanomolar in vitro activity against human 5-HT(3)A receptors. A chemistry optimization program was conducted and identified 2-aminobenzoxazoles as orally active 5-HT(3) receptor antagonists with good metabolic stability. These novel analogues possess drug-like characteristics and have potential utility for the treatment of diseases attributable to improper 5-HT(3) receptor function, especially diarrhea predominant irritable bowel syndrome (IBS-D).
Bioorganic & Medicinal Chemistry Letters | 2012
Anthony D. Pechulis; James P. Beck; Matt A. Curry; Mark A. Wolf; Arthur E. Harms; Ning Xi; Chet Opalka; Mark P. Sweet; Zhicai Yang; A. Samuel Vellekoop; Andrew M. Klos; Peter J. Crocker; Carla Hassler; Mia Laws; Douglas B. Kitchen; Mark A. Smith; Richard E. Olson; Shuang Liu; Bruce F. Molino
Novel 4-phenyl tetrahydroisoquinolines that inhibit both dopamine and norepinephrine transporters were designed and prepared. In this Letter, we describe the synthesis, in vitro activity and associated structure-activity relationships of this series. We also report the ex vivo NET occupancy of a representative compound, 41.
Archive | 2005
Bruce F. Molino; Zhicai Yang
Archive | 2005
Bruce F. Molino; Zhicai Yang
Archive | 2005
Bruce F. Molino; Zhicai Yang
Archive | 2007
Zhicai Yang; David D. Manning
Journal of Organic Chemistry | 2012
Zhicai Yang; Xiaomin Jin; Michael A. Guaciaro; Bruce F. Molino
Organic Letters | 2011
Zhicai Yang; Xiaomin Jin; Michael Guaciaro; Bruce F. Molino; Ursula Mocek; Ricardo Reategui; Joshua Rhea; Tim Morley
Archive | 2005
Bruce F. Molino; Zhicai Yang